Skip to main content

Table 1 Study subject serology results and indicators

From: Detection of hepatitis C virus in the nasal secretions of an intranasal drug-user

Subjects HCV PCR Copies per ml (Date of test) HepBsAb HepBsAg HepBcAb HIV Viral Load Copies per ml ALT U/L Liver Biopsy
1 10,800,000
(11/99)
Neg Neg Pos 633
(12/03)
32 (12/03) Activity: Mild Stage 2 of 4
(08/00)
  34,500,000 IU (12/03)     270,000
(01/03)
  
2 8,360,000
(09/99)
Neg Neg Pos 180,000
(10/03)
16
(02/04)
Not done due to bleeding diathesis
      96,000
(02/04)
16
(10/03)
 
3 1,320,000
(10/03)
Pos Neg Pos 16,900
(02/04)
110
(10/03)
Grade 2/3 of 4 Stage 2/3 of 4 (11/03)
       182
(02/04)
 
4 234,000
(12/02)
Neg Neg Neg 72,031
(12/02)
37
(12/03)
Grade 1 of 4 Stage 1 of 4
(11/03)
      <50
(12/03)
  
5 <600 Neg Neg Pos 212,000
(10/03)
41
(10/03)
Not done
       104
(04/04)
 
  1. HCV = hepatitis C virus; HepB = hepatitis B; s = surface; c = core; Ab = antibody; Ag = antigen; HIV = human immunodeficiency virus; ALT = alanine aminotransferase enzyme